Keywords: Actemra; Arava; Aristospan; Avsola; COVID-19; Celebrex; Cimzia; Comirnaty; DMARDs; Depo-Medrol; Enbrel; Humira; Inflectra; JAK inhibitors; Kevzara; NSAIDs; Olumiant; Orencia; Otrexup; PennSaid; Plaquenil; Questran; Rasuvo; Reditrex; Remicade; Renflexis; Riabni; Rinvoq; Rituxan; Ruxience; Simponi; Spikevax; TNF inhibitors; Trexall; Truxima; Voltaren; Xatmep; Xeljanz; abatacept; adalimumab; adverse effects; baricitinib; biologic; celecoxib; certolizumab; corticosteroids; diclofenac; drug interactions; etanercept; golimumab; hydroxychloroquine; infliximab; lactation; leflunomide; methotrexate; methylprednisolone; prednisone; pregnancy; rheumatoid arthritis; rituximab; safety; sarilumab; sulfasalazine; tocilizumab; tofacitinib; triamcinolone; upadacitinib; vaccines.